Allogeneic transplant (related or unrelated donor) is the preferred treatment for adult Philadelphia chromosome positive (Ph plus) acute lymphoblastic leukaemia (ALL). Results from the international ALL trial (MRC UKALLXII/ECOG E2993).
Main Authors: | , , , , , , , , , |
---|---|
Format: | Journal article |
Published: |
2001
|